The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials
Authors
Keywords
-
Journal
Obesity Reviews
Volume 17, Issue 12, Pages 1329-1340
Publisher
Wiley
Online
2016-07-26
DOI
10.1111/obr.12458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial
- (2015) Sony S Thazhath et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- (2015) Forouzan Faghihzadeh et al. BRITISH JOURNAL OF NUTRITION
- Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials
- (2015) Yanxia Liu et al. CLINICAL NUTRITION
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
- (2015) Sanne M. van der Made et al. PLoS One
- Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials
- (2014) Kai Liu et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- The Clinical Practice Recommendations of the German Diabetes Association
- (2014) EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study
- (2014) Stephen D. Anton et al. EXPERIMENTAL GERONTOLOGY
- Effects of Resveratrol on Memory Performance, Hippocampal Functional Connectivity, and Glucose Metabolism in Healthy Older Adults
- (2014) A. V. Witte et al. JOURNAL OF NEUROSCIENCE
- Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
- (2014) Miriam Méndez-del Villar et al. Metabolic Syndrome and Related Disorders
- Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis
- (2014) Heather A. Hausenblas et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Assessment of diet quality improves the classification ability of cardiovascular risk score in predicting future events: The 10-year follow-up of the ATTICA study (2002–2012)
- (2014) Ekavi N Georgousopoulou et al. European Journal of Preventive Cardiology
- Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective
- (2013) João Tomé-Carneiro et al. Annals of the New York Academy of Sciences
- High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men
- (2013) Satya Dash et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
- (2013) Ali Movahed et al. Evidence-based Complementary and Alternative Medicine
- Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults
- (2013) Rachel H.X. Wong et al. JOURNAL OF HYPERTENSION
- Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men
- (2013) Lasse Gliemann et al. JOURNAL OF PHYSIOLOGY-LONDON
- One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease
- (2012) João Tomé-Carneiro et al. AMERICAN JOURNAL OF CARDIOLOGY
- Inflammation and metabolic dysfunction: links to cardiovascular diseases
- (2012) Annika Taube et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease
- (2012) João Tomé-Carneiro et al. CARDIOVASCULAR DRUGS AND THERAPY
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Obesity, inflammation and the immune system
- (2012) Fátima Pérez de Heredia et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
- (2011) C Herder et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Residual cardiovascular risk in secondary prevention
- (2011) Alberto Zambon Internal and Emergency Medicine
- Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment
- (2011) Keisuke Fujitaka et al. NUTRITION RESEARCH
- Resveratrol and cardiovascular health
- (2010) Manika Das et al. MOLECULAR ASPECTS OF MEDICINE
- Central Administration of Resveratrol Improves Diet-Induced Diabetes
- (2009) Giorgio Ramadori et al. ENDOCRINOLOGY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started